Clinical trial

A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis

NCT00299104

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE3

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2017-07-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

folateDRUG

methotrexateDRUG · verified · RxNorm: methotrexate

methylprednisoloneDRUG · verified · RxNorm: methylprednisolone

placeboDRUG

rituximabDRUG · verified · RxNorm: rituximab

Sponsors & collaborators

Genentech, Inc.lead sponsor

Hoffmann-La Rochecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00299104 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.